Why the study?
Variability and cumulative exposure to serum cholesterol have been linked to cardiovascular outcomes, but their distinct impacts on MACEs in elderly patients remained unclear.
Does high cholesterol variability increase the risk of major adverse cardiovascular events in elderly patients not on cholesterol-lowering therapy?
Does high cholesterol variability increase the risk of major adverse cardiovascular events in elderly patients not on cholesterol-lowering therapy?
In elderly patients not on lipid-lowering therapy, visit-to-visit cholesterol variability is a stronger independent predictor of major adverse cardiovascular events than cumulative cholesterol exposure.
May support monitoring cholesterol variability in elderly patients; hypothesis-generating and requires prospective validation before practice change.
Background and Objectives: Variability and cumulative exposure to serum cholesterol have been linked to cardiovascular outcomes.This study aimed to distinguish their impact on major adverse cardiovascular events (MACEs) in elderly patients.Methods: Data from 4,413 elderly patients who are not maintained on cholesterol-lowering therapy for 8 years from 3 Korean tertiary hospitals were analyzed.Based on 8-year cholesterol levels, patients were grouped through coefficient of variation (CV) and cumulative exposure estimates (CEEs).MACE outcomes (death, myocardial infarction [MI], and stroke) over the next 5 years were then compared between these groups.Results: The average patient age was 70.5 years with 56.1% comprising of male participants.A higher CV was associated with increased cardiovascular risks; however, CEE did not demonstrate such trend.A weak negative correlation was found between CV and CEE ( = -0.22,p<0.01).The high-CV/low-CEE group had the highest MACE rate, whereas the low-CV/high-CEE group had the lowest (13.1% vs. 4.7%, p<0.01).The MACE variance was mainly attributed to the differences in death and MIs.A high CV emerged as an independent risk factor, regardless of CEE.Conclusions: Among the elderly, cholesterol variability between visits was more indicative of MACE than cumulative cholesterol exposure over time.
No takes yet. Share an insight, caveat, or question.
Yum et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: